摘要
神经性皮炎35例与湿疹21例采用0.1%氢化可的松17 α丁酯霜治疗;另外神经性皮炎35例与湿疹19例采用0.1%曲安萘德霜治疗;后者作为对照组进行双盲法试验。结果表明2组的疗效无显著性差异(P>0.05)。证明了没有氟的氢化可的松17 α丁酯霜与曲安萘德霜在相同浓度㈠广效相同。
In this double-blind test, 110 patients with neurodermatitis and eczema were divided into topical 0.1% cream hydrocortisone 17 a -butyrate(n= 56, neurodermatitis 35, eczema 21)and 0.1% cream triamcinolone acetonide(n=54, neurodermatitis 35, eczema 19)groups. The results showed that there was no significant difference in the therapeutic effects between them,(P>0.05). It is demonstrated that a non-halogenated corticosteroid is proven to be as effective as triamcinolone acetonide in the same concentration.
出处
《新药与临床》
CSCD
北大核心
1993年第2期85-87,共3页
关键词
氢化可的松
神经性皮炎
曲安萘德
hydrocortisone butyrate/therapeutie use
triamcinolone acetonide/therapeutic use
neurodermatitis/drug therapy
eczema/drug therapy